The clearance of the gene expression reagents makes Affymetrix the first firm to provide a "comprehensive microarray-based clinical toolkit for diagnostic test development, signature discovery for companion diagnostics, and translational initiatives," it said.
OptiGene will develop, manufacture, and sell nucleic acid amplification reagents for research use, and VLA will develop, manufacture, and provide testing for nucleic acid diagnostics for veterinary purposes and environmental monitoring.
The acquisition will add reagents for nucleic acid and protein purification, restriction and modifying enzymes, and other life science research and diagnostic tools to Thermo's Analytical Technologies portfolio.
The dispute stems from a licensing agreement in 2005 covering reagent patents held by Abaxis. Cepheid filed a countersuit yesterday, claiming it has not breached the license and asking the court to declare Abaxis' patents invalid.